Literature DB >> 3130236

Suppression of chemotaxis to corneal inflammation by nitrous oxide.

B J Kripke1, A Kupferman, K C Luu.   

Abstract

Immune competency is depressed in the perioperative period. The role of anesthetic agents in immune reactivity remains unclear. The chemotactic migration of polymorphonuclear leukocytes (PMNs) to the cornea of rabbits injured by clove oil was studied. PMNs were previously radiolabeled with tritiated (3H) thymidine. Immediately following injury, the rabbits entered isolation chambers and breathed either air or air containing 10%, 20% or 40% nitrous oxide (N2O) for 24 hours. After sacrifice, the radioactivity of a 10 mm corneal button, removed by trephination, was determined by scintillation counting technique. Peripheral blood was obtained for hemoglobin, white cell and platelet count. The N2O dosage affected on the migration of PMNs to the cornea. 3H was decreased 15.4% by 20% N2O and 38.8% for 40% N2O-exposed rabbits. Peripheral blood values did not differ. N2O can suppress chemotaxis of PMNs in the rabbit, thereby adversely affecting the inflammatory component of immune defense.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3130236

Source DB:  PubMed          Journal:  Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi        ISSN: 0253-2662


  3 in total

1.  Anesthetics or anesthetic techniques and cancer surgical outcomes: a possible link.

Authors:  Azeem Alam; Sanketh Rampes; Sonam Patel; Zac Hana; Daqing Ma
Journal:  Korean J Anesthesiol       Date:  2021-02-17

Review 2.  Nitrous oxide-based techniques versus nitrous oxide-free techniques for general anaesthesia.

Authors:  Rao Sun; Wen Qin Jia; Peng Zhang; KeHu Yang; Jin Hui Tian; Bin Ma; Yali Liu; Run H Jia; Xiao F Luo; Akira Kuriyama
Journal:  Cochrane Database Syst Rev       Date:  2015-11-06

3.  Nitrous oxide may not increase the risk of cancer recurrence after colorectal surgery: a follow-up of a randomized controlled trial.

Authors:  Edith Fleischmann; Corinna Marschalek; Katja Schlemitz; Jarrod E Dalton; Thomas Gruenberger; Friedrich Herbst; Andrea Kurz; Daniel I Sessler
Journal:  BMC Anesthesiol       Date:  2009-02-03       Impact factor: 2.217

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.